カテゴリー： 世界, 医療/バイオ, LP Information

世界の出血防止ジェル市場予測 2023年-2029年

【英語タイトル】Global Antibleeding Gel Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4066）・商品コード：LP23MY4066
・発行会社（調査会社）：LP Information
・発行日：2023年5月
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥534,360見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥801,540見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,068,720見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の出血防止ジェル市場」は、過去の販売実績から2022年の世界の出血防止ジェルの総販売量を検討し、2023年から2029年の予測される出血防止ジェルの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の出血防止ジェルの市場規模を掲載し、XXX百万米ドル規模の世界の出血防止ジェル市場の詳細な分析を提供します。本インサイトレポートは、世界の出血防止ジェル業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の出血防止ジェル市場における各社の独自のポジションをより深く理解するために、出血防止ジェル製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の出血防止ジェル市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。出血防止ジェルの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。出血防止ジェルの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。出血防止ジェルのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

出血防止ジェルの世界主要メーカーとしては、Integra LifeSciences Corporation、 Baxter International Inc.、 Z-Medica, LLC、 Johnson & Johnson(Ethicon, Inc.)、 Pfizer Inc.、 Becton, Dickinson and Company、 Hemcon Medical Technologies Inc.,、 Abbott Laboratories、 Johnson & Johnson、 CryoLife, Inc.、 Cresilon、 Advanced Medical Solutions Group plc、 CSL Behringなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の出血防止ジェル市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では出血防止ジェル市場をセグメンテーションし、種類別 (獣医用、ヒト用)、用途別 (小売薬局、動物用薬局、オンライン薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：獣医用、ヒト用

・用途別区分：小売薬局、動物用薬局、オンライン薬局、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の出血防止ジェル市場の10年間の市場状況・展望は？
・世界および地域別に見た出血防止ジェル市場成長の要因は何か？
・出血防止ジェルの市場機会はエンドマーケットの規模によってどのように変化するのか？
・出血防止ジェルのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：出血防止ジェルの年間販売量2018-2029、地域別現状・将来分析
・出血防止ジェルの種類別セグメント：獣医用、ヒト用
・出血防止ジェルの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・出血防止ジェルの用途別セグメント：小売薬局、動物用薬局、オンライン薬局、その他
・出血防止ジェルの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の出血防止ジェル市場
・企業別のグローバル出血防止ジェル市場データ：2018-2023年の年間販売量、市場シェア
・企業別の出血防止ジェルの年間売上：2018-2023年の売上、市場シェア
・企業別の出血防止ジェル販売価格
・主要企業の出血防止ジェル生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

出血防止ジェルの地域別レビュー
・地域別の出血防止ジェル市場規模2018-2023：年間販売量、売上
・主要国別の出血防止ジェル市場規模2018-2023：年間販売量、売上
・南北アメリカの出血防止ジェル販売の成長
・アジア太平洋の出血防止ジェル販売の成長
・ヨーロッパの出血防止ジェル販売の成長
・中東・アフリカの出血防止ジェル販売の成長

南北アメリカ市場
・南北アメリカの国別の出血防止ジェル販売量、売上（2018-2023）
・南北アメリカの出血防止ジェルの種類別販売量
・南北アメリカの出血防止ジェルの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の出血防止ジェル販売量、売上（2018-2023）
・アジア太平洋の出血防止ジェルの種類別販売量
・アジア太平洋の出血防止ジェルの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の出血防止ジェル販売量、売上（2018-2023）
・ヨーロッパの出血防止ジェルの種類別販売量
・ヨーロッパの出血防止ジェルの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の出血防止ジェル販売量、売上（2018-2023）
・中東・アフリカの出血防止ジェルの種類別販売量
・中東・アフリカの出血防止ジェルの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・出血防止ジェルの製造コスト構造分析
・出血防止ジェルの製造プロセス分析
・出血防止ジェルの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・出血防止ジェルの主要なグローバル販売業者
・出血防止ジェルの主要なグローバル顧客

地域別の出血防止ジェル市場予測レビュー
・地域別の出血防止ジェル市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・出血防止ジェルの種類別市場規模予測
・出血防止ジェルの用途別市場規模予測

主要企業分析
Integra LifeSciences Corporation、 Baxter International Inc.、 Z-Medica, LLC、 Johnson & Johnson(Ethicon, Inc.)、 Pfizer Inc.、 Becton, Dickinson and Company、 Hemcon Medical Technologies Inc.,、 Abbott Laboratories、 Johnson & Johnson、 CryoLife, Inc.、 Cresilon、 Advanced Medical Solutions Group plc、 CSL Behring
・企業情報
・出血防止ジェル製品
・出血防止ジェル販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Antibleeding gel is a semi-clear gel that instantly prevents both the internal and external bleeding.
LPI (LP Information)’ newest research report, the “Antibleeding Gel Industry Forecast” looks at past sales and reviews total world Antibleeding Gel sales in 2022, providing a comprehensive analysis by region and market sector of projected Antibleeding Gel sales for 2023 through 2029. With Antibleeding Gel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibleeding Gel industry.
This Insight Report provides a comprehensive analysis of the global Antibleeding Gel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibleeding Gel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibleeding Gel market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibleeding Gel and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibleeding Gel.
The global Antibleeding Gel market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Antibleeding Gel is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antibleeding Gel is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antibleeding Gel is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antibleeding Gel players cover Integra LifeSciences Corporation, Baxter International Inc., Z-Medica, LLC, Johnson & Johnson(Ethicon, Inc.), Pfizer Inc., Becton, Dickinson and Company, Hemcon Medical Technologies Inc.,, Abbott Laboratories and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Antibleeding Gel market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
by Product Type
Veterinary Use
Human Use
by Indication
Biopsies of Soft Tissue
Trauma
Enucleations
Orthopedic Surgeries
Others
Segmentation by application
Retail Pharmacy
Veterinary Pharmacy
Online Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Integra LifeSciences Corporation
Baxter International Inc.
Z-Medica, LLC
Johnson & Johnson(Ethicon, Inc.)
Pfizer Inc.
Becton, Dickinson and Company
Hemcon Medical Technologies Inc.,
Abbott Laboratories
Johnson & Johnson
CryoLife, Inc.
Cresilon
Advanced Medical Solutions Group plc
CSL Behring
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antibleeding Gel market?
What factors are driving Antibleeding Gel market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antibleeding Gel market opportunities vary by end market size?
How does Antibleeding Gel break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibleeding Gel Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antibleeding Gel by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antibleeding Gel by Country/Region, 2018, 2022 & 2029
2.2 Antibleeding Gel Segment by Type
2.2.1 Veterinary Use
2.2.2 Human Use
2.3 Antibleeding Gel Sales by Type
2.3.1 Global Antibleeding Gel Sales Market Share by Type (2018-2023)
2.3.2 Global Antibleeding Gel Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antibleeding Gel Sale Price by Type (2018-2023)
2.4 Antibleeding Gel Segment by Application
2.4.1 Retail Pharmacy
2.4.2 Veterinary Pharmacy
2.4.3 Online Pharmacy
2.4.4 Others
2.5 Antibleeding Gel Sales by Application
2.5.1 Global Antibleeding Gel Sale Market Share by Application (2018-2023)
2.5.2 Global Antibleeding Gel Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antibleeding Gel Sale Price by Application (2018-2023)
3 Global Antibleeding Gel by Company
3.1 Global Antibleeding Gel Breakdown Data by Company
3.1.1 Global Antibleeding Gel Annual Sales by Company (2018-2023)
3.1.2 Global Antibleeding Gel Sales Market Share by Company (2018-2023)
3.2 Global Antibleeding Gel Annual Revenue by Company (2018-2023)
3.2.1 Global Antibleeding Gel Revenue by Company (2018-2023)
3.2.2 Global Antibleeding Gel Revenue Market Share by Company (2018-2023)
3.3 Global Antibleeding Gel Sale Price by Company
3.4 Key Manufacturers Antibleeding Gel Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antibleeding Gel Product Location Distribution
3.4.2 Players Antibleeding Gel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antibleeding Gel by Geographic Region
4.1 World Historic Antibleeding Gel Market Size by Geographic Region (2018-2023)
4.1.1 Global Antibleeding Gel Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antibleeding Gel Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antibleeding Gel Market Size by Country/Region (2018-2023)
4.2.1 Global Antibleeding Gel Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antibleeding Gel Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antibleeding Gel Sales Growth
4.4 APAC Antibleeding Gel Sales Growth
4.5 Europe Antibleeding Gel Sales Growth
4.6 Middle East & Africa Antibleeding Gel Sales Growth
5 Americas
5.1 Americas Antibleeding Gel Sales by Country
5.1.1 Americas Antibleeding Gel Sales by Country (2018-2023)
5.1.2 Americas Antibleeding Gel Revenue by Country (2018-2023)
5.2 Americas Antibleeding Gel Sales by Type
5.3 Americas Antibleeding Gel Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antibleeding Gel Sales by Region
6.1.1 APAC Antibleeding Gel Sales by Region (2018-2023)
6.1.2 APAC Antibleeding Gel Revenue by Region (2018-2023)
6.2 APAC Antibleeding Gel Sales by Type
6.3 APAC Antibleeding Gel Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antibleeding Gel by Country
7.1.1 Europe Antibleeding Gel Sales by Country (2018-2023)
7.1.2 Europe Antibleeding Gel Revenue by Country (2018-2023)
7.2 Europe Antibleeding Gel Sales by Type
7.3 Europe Antibleeding Gel Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antibleeding Gel by Country
8.1.1 Middle East & Africa Antibleeding Gel Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antibleeding Gel Revenue by Country (2018-2023)
8.2 Middle East & Africa Antibleeding Gel Sales by Type
8.3 Middle East & Africa Antibleeding Gel Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibleeding Gel
10.3 Manufacturing Process Analysis of Antibleeding Gel
10.4 Industry Chain Structure of Antibleeding Gel
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antibleeding Gel Distributors
11.3 Antibleeding Gel Customer
12 World Forecast Review for Antibleeding Gel by Geographic Region
12.1 Global Antibleeding Gel Market Size Forecast by Region
12.1.1 Global Antibleeding Gel Forecast by Region (2024-2029)
12.1.2 Global Antibleeding Gel Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibleeding Gel Forecast by Type
12.7 Global Antibleeding Gel Forecast by Application
13 Key Players Analysis
13.1 Integra LifeSciences Corporation
13.1.1 Integra LifeSciences Corporation Company Information
13.1.2 Integra LifeSciences Corporation Antibleeding Gel Product Portfolios and Specifications
13.1.3 Integra LifeSciences Corporation Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Integra LifeSciences Corporation Main Business Overview
13.1.5 Integra LifeSciences Corporation Latest Developments
13.2 Baxter International Inc.
13.2.1 Baxter International Inc. Company Information
13.2.2 Baxter International Inc. Antibleeding Gel Product Portfolios and Specifications
13.2.3 Baxter International Inc. Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Baxter International Inc. Main Business Overview
13.2.5 Baxter International Inc. Latest Developments
13.3 Z-Medica, LLC
13.3.1 Z-Medica, LLC Company Information
13.3.2 Z-Medica, LLC Antibleeding Gel Product Portfolios and Specifications
13.3.3 Z-Medica, LLC Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Z-Medica, LLC Main Business Overview
13.3.5 Z-Medica, LLC Latest Developments
13.4 Johnson & Johnson(Ethicon, Inc.)
13.4.1 Johnson & Johnson(Ethicon, Inc.) Company Information
13.4.2 Johnson & Johnson(Ethicon, Inc.) Antibleeding Gel Product Portfolios and Specifications
13.4.3 Johnson & Johnson(Ethicon, Inc.) Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Johnson & Johnson(Ethicon, Inc.) Main Business Overview
13.4.5 Johnson & Johnson(Ethicon, Inc.) Latest Developments
13.5 Pfizer Inc.
13.5.1 Pfizer Inc. Company Information
13.5.2 Pfizer Inc. Antibleeding Gel Product Portfolios and Specifications
13.5.3 Pfizer Inc. Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Pfizer Inc. Main Business Overview
13.5.5 Pfizer Inc. Latest Developments
13.6 Becton, Dickinson and Company
13.6.1 Becton, Dickinson and Company Company Information
13.6.2 Becton, Dickinson and Company Antibleeding Gel Product Portfolios and Specifications
13.6.3 Becton, Dickinson and Company Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Becton, Dickinson and Company Main Business Overview
13.6.5 Becton, Dickinson and Company Latest Developments
13.7 Hemcon Medical Technologies Inc.,
13.7.1 Hemcon Medical Technologies Inc., Company Information
13.7.2 Hemcon Medical Technologies Inc., Antibleeding Gel Product Portfolios and Specifications
13.7.3 Hemcon Medical Technologies Inc., Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hemcon Medical Technologies Inc., Main Business Overview
13.7.5 Hemcon Medical Technologies Inc., Latest Developments
13.8 Abbott Laboratories
13.8.1 Abbott Laboratories Company Information
13.8.2 Abbott Laboratories Antibleeding Gel Product Portfolios and Specifications
13.8.3 Abbott Laboratories Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Abbott Laboratories Main Business Overview
13.8.5 Abbott Laboratories Latest Developments
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Information
13.9.2 Johnson & Johnson Antibleeding Gel Product Portfolios and Specifications
13.9.3 Johnson & Johnson Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Johnson & Johnson Main Business Overview
13.9.5 Johnson & Johnson Latest Developments
13.10 CryoLife, Inc.
13.10.1 CryoLife, Inc. Company Information
13.10.2 CryoLife, Inc. Antibleeding Gel Product Portfolios and Specifications
13.10.3 CryoLife, Inc. Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 CryoLife, Inc. Main Business Overview
13.10.5 CryoLife, Inc. Latest Developments
13.11 Cresilon
13.11.1 Cresilon Company Information
13.11.2 Cresilon Antibleeding Gel Product Portfolios and Specifications
13.11.3 Cresilon Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Cresilon Main Business Overview
13.11.5 Cresilon Latest Developments
13.12 Advanced Medical Solutions Group plc
13.12.1 Advanced Medical Solutions Group plc Company Information
13.12.2 Advanced Medical Solutions Group plc Antibleeding Gel Product Portfolios and Specifications
13.12.3 Advanced Medical Solutions Group plc Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Advanced Medical Solutions Group plc Main Business Overview
13.12.5 Advanced Medical Solutions Group plc Latest Developments
13.13 CSL Behring
13.13.1 CSL Behring Company Information
13.13.2 CSL Behring Antibleeding Gel Product Portfolios and Specifications
13.13.3 CSL Behring Antibleeding Gel Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 CSL Behring Main Business Overview
13.13.5 CSL Behring Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Antibleeding Gel Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antibleeding Gel Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Veterinary Use
Table 4. Major Players of Human Use
Table 5. Global Antibleeding Gel Sales by Type (2018-2023) & (K Units)
Table 6. Global Antibleeding Gel Sales Market Share by Type (2018-2023)
Table 7. Global Antibleeding Gel Revenue by Type (2018-2023) & ($ million)
Table 8. Global Antibleeding Gel Revenue Market Share by Type (2018-2023)
Table 9. Global Antibleeding Gel Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Antibleeding Gel Sales by Application (2018-2023) & (K Units)
Table 11. Global Antibleeding Gel Sales Market Share by Application (2018-2023)
Table 12. Global Antibleeding Gel Revenue by Application (2018-2023)
Table 13. Global Antibleeding Gel Revenue Market Share by Application (2018-2023)
Table 14. Global Antibleeding Gel Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Antibleeding Gel Sales by Company (2018-2023) & (K Units)
Table 16. Global Antibleeding Gel Sales Market Share by Company (2018-2023)
Table 17. Global Antibleeding Gel Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Antibleeding Gel Revenue Market Share by Company (2018-2023)
Table 19. Global Antibleeding Gel Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Antibleeding Gel Producing Area Distribution and Sales Area
Table 21. Players Antibleeding Gel Products Offered
Table 22. Antibleeding Gel Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antibleeding Gel Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Antibleeding Gel Sales Market Share Geographic Region (2018-2023)
Table 27. Global Antibleeding Gel Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Antibleeding Gel Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Antibleeding Gel Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Antibleeding Gel Sales Market Share by Country/Region (2018-2023)
Table 31. Global Antibleeding Gel Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Antibleeding Gel Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Antibleeding Gel Sales by Country (2018-2023) & (K Units)
Table 34. Americas Antibleeding Gel Sales Market Share by Country (2018-2023)
Table 35. Americas Antibleeding Gel Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Antibleeding Gel Revenue Market Share by Country (2018-2023)
Table 37. Americas Antibleeding Gel Sales by Type (2018-2023) & (K Units)
Table 38. Americas Antibleeding Gel Sales by Application (2018-2023) & (K Units)
Table 39. APAC Antibleeding Gel Sales by Region (2018-2023) & (K Units)
Table 40. APAC Antibleeding Gel Sales Market Share by Region (2018-2023)
Table 41. APAC Antibleeding Gel Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Antibleeding Gel Revenue Market Share by Region (2018-2023)
Table 43. APAC Antibleeding Gel Sales by Type (2018-2023) & (K Units)
Table 44. APAC Antibleeding Gel Sales by Application (2018-2023) & (K Units)
Table 45. Europe Antibleeding Gel Sales by Country (2018-2023) & (K Units)
Table 46. Europe Antibleeding Gel Sales Market Share by Country (2018-2023)
Table 47. Europe Antibleeding Gel Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Antibleeding Gel Revenue Market Share by Country (2018-2023)
Table 49. Europe Antibleeding Gel Sales by Type (2018-2023) & (K Units)
Table 50. Europe Antibleeding Gel Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Antibleeding Gel Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Antibleeding Gel Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Antibleeding Gel Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Antibleeding Gel Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Antibleeding Gel Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Antibleeding Gel Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Antibleeding Gel
Table 58. Key Market Challenges & Risks of Antibleeding Gel
Table 59. Key Industry Trends of Antibleeding Gel
Table 60. Antibleeding Gel Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Antibleeding Gel Distributors List
Table 63. Antibleeding Gel Customer List
Table 64. Global Antibleeding Gel Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Antibleeding Gel Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Antibleeding Gel Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Antibleeding Gel Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Antibleeding Gel Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Antibleeding Gel Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Antibleeding Gel Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Antibleeding Gel Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Antibleeding Gel Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Antibleeding Gel Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Antibleeding Gel Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Antibleeding Gel Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Antibleeding Gel Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Antibleeding Gel Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Integra LifeSciences Corporation Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 79. Integra LifeSciences Corporation Antibleeding Gel Product Portfolios and Specifications
Table 80. Integra LifeSciences Corporation Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Integra LifeSciences Corporation Main Business
Table 82. Integra LifeSciences Corporation Latest Developments
Table 83. Baxter International Inc. Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 84. Baxter International Inc. Antibleeding Gel Product Portfolios and Specifications
Table 85. Baxter International Inc. Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Baxter International Inc. Main Business
Table 87. Baxter International Inc. Latest Developments
Table 88. Z-Medica, LLC Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 89. Z-Medica, LLC Antibleeding Gel Product Portfolios and Specifications
Table 90. Z-Medica, LLC Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Z-Medica, LLC Main Business
Table 92. Z-Medica, LLC Latest Developments
Table 93. Johnson & Johnson(Ethicon, Inc.) Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson(Ethicon, Inc.) Antibleeding Gel Product Portfolios and Specifications
Table 95. Johnson & Johnson(Ethicon, Inc.) Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Johnson & Johnson(Ethicon, Inc.) Main Business
Table 97. Johnson & Johnson(Ethicon, Inc.) Latest Developments
Table 98. Pfizer Inc. Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Inc. Antibleeding Gel Product Portfolios and Specifications
Table 100. Pfizer Inc. Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Pfizer Inc. Main Business
Table 102. Pfizer Inc. Latest Developments
Table 103. Becton, Dickinson and Company Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 104. Becton, Dickinson and Company Antibleeding Gel Product Portfolios and Specifications
Table 105. Becton, Dickinson and Company Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Becton, Dickinson and Company Main Business
Table 107. Becton, Dickinson and Company Latest Developments
Table 108. Hemcon Medical Technologies Inc., Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 109. Hemcon Medical Technologies Inc., Antibleeding Gel Product Portfolios and Specifications
Table 110. Hemcon Medical Technologies Inc., Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Hemcon Medical Technologies Inc., Main Business
Table 112. Hemcon Medical Technologies Inc., Latest Developments
Table 113. Abbott Laboratories Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 114. Abbott Laboratories Antibleeding Gel Product Portfolios and Specifications
Table 115. Abbott Laboratories Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Abbott Laboratories Main Business
Table 117. Abbott Laboratories Latest Developments
Table 118. Johnson & Johnson Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 119. Johnson & Johnson Antibleeding Gel Product Portfolios and Specifications
Table 120. Johnson & Johnson Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Johnson & Johnson Main Business
Table 122. Johnson & Johnson Latest Developments
Table 123. CryoLife, Inc. Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 124. CryoLife, Inc. Antibleeding Gel Product Portfolios and Specifications
Table 125. CryoLife, Inc. Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. CryoLife, Inc. Main Business
Table 127. CryoLife, Inc. Latest Developments
Table 128. Cresilon Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 129. Cresilon Antibleeding Gel Product Portfolios and Specifications
Table 130. Cresilon Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Cresilon Main Business
Table 132. Cresilon Latest Developments
Table 133. Advanced Medical Solutions Group plc Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 134. Advanced Medical Solutions Group plc Antibleeding Gel Product Portfolios and Specifications
Table 135. Advanced Medical Solutions Group plc Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Advanced Medical Solutions Group plc Main Business
Table 137. Advanced Medical Solutions Group plc Latest Developments
Table 138. CSL Behring Basic Information, Antibleeding Gel Manufacturing Base, Sales Area and Its Competitors
Table 139. CSL Behring Antibleeding Gel Product Portfolios and Specifications
Table 140. CSL Behring Antibleeding Gel Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. CSL Behring Main Business
Table 142. CSL Behring Latest Developments
List of Figures
Figure 1. Picture of Antibleeding Gel
Figure 2. Antibleeding Gel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibleeding Gel Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antibleeding Gel Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antibleeding Gel Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Veterinary Use
Figure 10. Product Picture of Human Use
Figure 11. Global Antibleeding Gel Sales Market Share by Type in 2022
Figure 12. Global Antibleeding Gel Revenue Market Share by Type (2018-2023)
Figure 13. Antibleeding Gel Consumed in Retail Pharmacy
Figure 14. Global Antibleeding Gel Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 15. Antibleeding Gel Consumed in Veterinary Pharmacy
Figure 16. Global Antibleeding Gel Market: Veterinary Pharmacy (2018-2023) & (K Units)
Figure 17. Antibleeding Gel Consumed in Online Pharmacy
Figure 18. Global Antibleeding Gel Market: Online Pharmacy (2018-2023) & (K Units)
Figure 19. Antibleeding Gel Consumed in Others
Figure 20. Global Antibleeding Gel Market: Others (2018-2023) & (K Units)
Figure 21. Global Antibleeding Gel Sales Market Share by Application (2022)
Figure 22. Global Antibleeding Gel Revenue Market Share by Application in 2022
Figure 23. Antibleeding Gel Sales Market by Company in 2022 (K Units)
Figure 24. Global Antibleeding Gel Sales Market Share by Company in 2022
Figure 25. Antibleeding Gel Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Antibleeding Gel Revenue Market Share by Company in 2022
Figure 27. Global Antibleeding Gel Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Antibleeding Gel Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Antibleeding Gel Sales 2018-2023 (K Units)
Figure 30. Americas Antibleeding Gel Revenue 2018-2023 ($ Millions)
Figure 31. APAC Antibleeding Gel Sales 2018-2023 (K Units)
Figure 32. APAC Antibleeding Gel Revenue 2018-2023 ($ Millions)
Figure 33. Europe Antibleeding Gel Sales 2018-2023 (K Units)
Figure 34. Europe Antibleeding Gel Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Antibleeding Gel Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Antibleeding Gel Revenue 2018-2023 ($ Millions)
Figure 37. Americas Antibleeding Gel Sales Market Share by Country in 2022
Figure 38. Americas Antibleeding Gel Revenue Market Share by Country in 2022
Figure 39. Americas Antibleeding Gel Sales Market Share by Type (2018-2023)
Figure 40. Americas Antibleeding Gel Sales Market Share by Application (2018-2023)
Figure 41. United States Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Antibleeding Gel Sales Market Share by Region in 2022
Figure 46. APAC Antibleeding Gel Revenue Market Share by Regions in 2022
Figure 47. APAC Antibleeding Gel Sales Market Share by Type (2018-2023)
Figure 48. APAC Antibleeding Gel Sales Market Share by Application (2018-2023)
Figure 49. China Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Antibleeding Gel Sales Market Share by Country in 2022
Figure 57. Europe Antibleeding Gel Revenue Market Share by Country in 2022
Figure 58. Europe Antibleeding Gel Sales Market Share by Type (2018-2023)
Figure 59. Europe Antibleeding Gel Sales Market Share by Application (2018-2023)
Figure 60. Germany Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Antibleeding Gel Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Antibleeding Gel Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Antibleeding Gel Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Antibleeding Gel Sales Market Share by Application (2018-2023)
Figure 69. Egypt Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Antibleeding Gel Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Antibleeding Gel in 2022
Figure 75. Manufacturing Process Analysis of Antibleeding Gel
Figure 76. Industry Chain Structure of Antibleeding Gel
Figure 77. Channels of Distribution
Figure 78. Global Antibleeding Gel Sales Market Forecast by Region (2024-2029)
Figure 79. Global Antibleeding Gel Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Antibleeding Gel Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Antibleeding Gel Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Antibleeding Gel Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Antibleeding Gel Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の出血防止ジェル市場予測 2023年-2029年] (コード：LP23MY4066)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の出血防止ジェル市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の自動注射器市場予測 2023年-2029年
  • 世界の塞栓剤市場予測 2023年-2029年
  • 世界のブレードレストロカール市場予測 2023年-2029年
  • 世界のブレードトロカール市場予測 2023年-2029年
  • 世界のデジタル瞳孔計市場予測 2023年-2029年
  • 世界の皮下注射針市場予測 2023年-2029年
  • 世界の在宅医療市場予測 2023年-2029年
  • 世界の使い捨て型トロカール市場予測 2023年-2029年
  • 世界のトロカールシステム市場予測 2023年-2029年
  • 世界の内視鏡治療装置市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆